Doma, S. A., Sever, M., Vidali, G. C., Podgornik, H. (2025). Venetoclax plus hypomethylating agent as first- and second-line treatment in patients with AML: A single-center experience. Blood. https://doi.org/10.1182/blood-2025-6988